Cargando…
High-dose IL-2 in metastatic melanoma: better survival in patients who also received patient-specific autologous tumor cell vaccine
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991382/ http://dx.doi.org/10.1186/2051-1426-1-S1-P208 |
| _version_ | 1782312427456561152 |
|---|---|
| author | Dillman, Robert O DePriest, Carol McClure, Stephanie E |
| author_facet | Dillman, Robert O DePriest, Carol McClure, Stephanie E |
| author_sort | Dillman, Robert O |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3991382 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-39913822014-05-05 High-dose IL-2 in metastatic melanoma: better survival in patients who also received patient-specific autologous tumor cell vaccine Dillman, Robert O DePriest, Carol McClure, Stephanie E J Immunother Cancer Poster Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3991382/ http://dx.doi.org/10.1186/2051-1426-1-S1-P208 Text en Copyright © 2013 Dillman et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster Presentation Dillman, Robert O DePriest, Carol McClure, Stephanie E High-dose IL-2 in metastatic melanoma: better survival in patients who also received patient-specific autologous tumor cell vaccine |
| title | High-dose IL-2 in metastatic melanoma: better survival in patients who also received patient-specific autologous tumor cell vaccine |
| title_full | High-dose IL-2 in metastatic melanoma: better survival in patients who also received patient-specific autologous tumor cell vaccine |
| title_fullStr | High-dose IL-2 in metastatic melanoma: better survival in patients who also received patient-specific autologous tumor cell vaccine |
| title_full_unstemmed | High-dose IL-2 in metastatic melanoma: better survival in patients who also received patient-specific autologous tumor cell vaccine |
| title_short | High-dose IL-2 in metastatic melanoma: better survival in patients who also received patient-specific autologous tumor cell vaccine |
| title_sort | high-dose il-2 in metastatic melanoma: better survival in patients who also received patient-specific autologous tumor cell vaccine |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991382/ http://dx.doi.org/10.1186/2051-1426-1-S1-P208 |
| work_keys_str_mv | AT dillmanroberto highdoseil2inmetastaticmelanomabettersurvivalinpatientswhoalsoreceivedpatientspecificautologoustumorcellvaccine AT depriestcarol highdoseil2inmetastaticmelanomabettersurvivalinpatientswhoalsoreceivedpatientspecificautologoustumorcellvaccine AT mcclurestephaniee highdoseil2inmetastaticmelanomabettersurvivalinpatientswhoalsoreceivedpatientspecificautologoustumorcellvaccine |